Maravai LifeSciences
MRVI
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. It also provides research products for labeling and detecting proteins in cells and tissue samples. Its products include CleanCap, messenger ribonucleic acid (mRNA) and oligonucleotide. The Biologics Safety Testing focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing spectrum. The Company provides ultra-pure nucleotides to customers in the diagnostics, pharma, genomics and research markets.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 11 days ago • MRVI
Maravai (MRVI) Advances in RNA Research With New CollaborationBusiness Wire • 15 days ago • MRVI
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation CenterGlobeNewsWire • 19 days ago • MRVI
Maravai LifeSciences Announces May and June 2024 Investor Conference ScheduleSeeking Alpha • 19 days ago • MRVI
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2024 Earnings Call TranscriptGlobeNewsWire • 20 days ago • MRVI
Maravai LifeSciences Reports First Quarter 2024 Financial ResultsCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.